Rationale and Objectives. We assessed the usefulness of the resistive
index (RI) and renal length in predicting a significant renal artery s
tenosis (RAS) and evaluated the effect of captopril on the RI in kidne
ys with and without a significant RAS. Methods. The RIs and renal leng
ths of both kidneys were measured in 39 patients who were referred for
captopril renography for suspected renovascular hypertension. The dif
ference in RIs (Delta RI), the smaller RI (SRI), the difference in len
gths (Delta L), and the shorter length (SL) of the patient's two kidne
ys were determined. The accuracy of each of these parameters was calcu
lated using captopril renography (n = 39) and arteriography (n = 9) as
the gold standards, Results. There was a significant difference in th
e Delta RI (p < .05), SRI (p < .001), and Delta L (p < .05) in patient
s with a positive captopril renogram for a significant RAS. Captopril
increased Delta RI (p = .052) in patients with a positive captopril re
nogram (n = 6). Use of an SRI threshold of less than .55 resulted in u
ltrasound being as accurate as captopril renography in predicting an a
ngio, graphically documented stenosis of greater than or equal to 50%.
Conclusion. The RI and renal length are useful in detecting a signifi
cant RAS. In this preliminary study, captopril was shown to increase D
elta RI in patients with a significant RAS, but larger prospective stu
dies are necessary to further assess the value of captopril sonography
in detecting a significant RAS.